C. Medri

The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review

A. Rovó, B. M. Taleghani, M. Diepold, 2021, Annals of Hematology.

Longitudinal analysis of antibody trajectories and humoral responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy (RituxiVac 2.0)

C. Hirzel, D. Sidler, L. Borradori, 2021, medRxiv.

Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case report

A. Rovó, A. Angelillo-Scherrer, A. Hammerer-Lercher, 2022, Journal of Medical Case Reports.

Platelet Transfusion—Insights from Current Practice to Future Development

S. Zeerleder, M. Daskalakis, K. Jalowiec, 2021, Journal of clinical medicine.

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy

C. Hirzel, D. Sidler, L. Borradori, 2022, RMD Open.

Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress® 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice

A. Rovó, C. Medri, T. Lehmann, 2022, Journal of clinical medicine.

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study

C. Hirzel, D. Sidler, L. Borradori, 2021, The Lancet Rheumatology.

Humoral and cellular responses to mRNA vaccines against SARS-CoV2 in patients with a history of CD20-B-cell depleting therapy

C. Hirzel, D. Sidler, L. Borradori, 2021, medRxiv.